desloratadine has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Döbbeling, U; Graf, N; Johansen, P; Kündig, TM; Waeckerle-Men, Y; Zabel, F | 1 |
1 other study(ies) available for desloratadine and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
The antihistamines clemastine and desloratadine inhibit STAT3 and c-Myc activities and induce apoptosis in cutaneous T-cell lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Clemastine; Cytoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histamine Antagonists; Humans; Loratadine; Lymphoma, T-Cell, Cutaneous; Proto-Oncogene Proteins c-myc; STAT3 Transcription Factor | 2013 |